Lipid-Based Pharma Excipients Market Revenue to Reach $1.32 Billion by 2030
"Lipid-Based Pharma Excipients Market Research Report by Arizton"
According to Arizton's latest research report, the lipid-based pharma excipients market is growing at a CAGR of 5.63% during 2024-2030.
Report Scope:
Market Size (2030): $1.32 Billion
Market Size (2024): $953.01 Million
CAGR (2024-2030): 5.63%
Historic Year: 2021-2023
Base Year: 2024
Forecast Year: 2025-2030
Market Segmentation: Product Type, Functionality, Formulation, End-User, and Geography
Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa
Competitive Landscape of the Global Lipid-Based Pharmaceutical Excipients Market
The global lipid-based pharmaceutical excipients market has experienced significant growth, driven by the increasing demand for advanced drug delivery systems and the need for high-quality excipients to improve drug formulations. Key lipid-based excipients, such as solid lipid nanoparticles, liposomes, and lipid emulsions, enhance the bioavailability, stability, and targeted delivery of poorly soluble drugs. As competition intensifies, companies are focusing on strategies such as product innovation, strategic partnerships, geographic expansion, and offering customized solutions to maintain competitiveness.
Major players, including BASF, Lonza, and Evonik Industries, are investing heavily in R&D, forming partnerships, and acquiring firms to expand their portfolios and market reach. North America remains the largest market, while APAC is the fastest-growing region due to rising pharmaceutical investments. Companies expanding into emerging markets like Latin America and the Middle East & Africa are also contributing to market growth. With continued demand for novel drug formulations, the lipid-based excipients market is expected to keep growing, driven by innovation and tailored solutions.
Europe Lipid-Based Pharma Excipients Market Growth and Challenges
The European lipid-based pharmaceutical excipients market is experiencing significant growth, driven by increasing demand for advanced drug delivery systems, especially for poorly soluble drugs. Lipid-based excipients like Solid Lipid Nanoparticles (SLNs) and Self-Emulsifying Drug Delivery Systems (SEDDS) enhance drug solubility and stability. The rise of biologics, mRNA-based therapies, and personalized medicine further boosts demand. The success of mRNA vaccines has increased interest in lipid nanoparticles (LNPs) for gene therapy and vaccines.
However, challenges such as supply chain disruptions, high production costs, and competition from synthetic excipients complicate market growth. Regulatory complexity, geopolitical tensions, and the limited number of specialized suppliers also impact the market. To address these, companies are investing in sustainable, domestic lipid production, while innovations in algae-derived and fermentation-based lipids are gaining traction to meet environmental and ethical standards. Despite these challenges, the market is poised for continued growth driven by advancements in drug delivery technologies.
Pharma & Biotech Companies are the Major End-Users
Lipid-based excipients have become a cornerstone in the pharmaceutical and biotechnology industries, playing a vital role in enhancing the solubility and bioavailability of lipophilic active ingredients, particularly in oral formulations. These excipients are increasingly used to improve the solubility of poorly water-soluble drugs, making them essential for drug development and manufacturing. The growing demand for lipid-based excipients is driven by pharmaceutical companies seeking to improve product quality, achieve high production volumes, and remain competitive.
With over 40,000 pharmaceutical companies globally, the demand for lipid-based excipients is significant, as they help optimize drug delivery systems and meet various requirements such as stability, efficacy, and route of administration. North America, Europe, and the APAC region account for about 75% of the global demand for lipid excipients, with the US leading in pharmaceutical production, contributing to nearly 45% of global drug manufacturing. China and Germany follow as major players in pharmaceutical production. APAC, particularly China, is emerging as a key hub for pharmaceutical manufacturing, creating substantial growth opportunities for lipid-based excipients in the region.
Advancements in Lipid Nanoparticles and Drug Delivery Systems
Lipid nanoparticles (LNPs) have emerged as a groundbreaking technology in the pharmaceutical industry, enhancing drug stability, bioavailability, and targeted delivery. LNPs, including solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and liposomes, are versatile drug carriers used to deliver a range of therapeutic agents. They offer advantages like improved solubility, stability, and targeted delivery, which reduce off-target effects and toxicity.
LNPs gained significant attention during the COVID-19 pandemic, playing a key role in mRNA vaccine development by protecting fragile mRNA and ensuring effective delivery into cells. The applications of LNPs are expanding in areas like cancer therapy, gene therapy, vaccines, and neurological disorders, notably allowing for targeted delivery and crossing the blood-brain barrier.
The growing focus on personalized medicine, chronic diseases, and precision therapies is driving further demand for lipid-based drug delivery systems. With increased R&D investments, regulatory support, and strategic partnerships, the market for lipid-based excipients is poised for substantial growth. The integration of AI and ML in drug formulation will further enhance the design and functionality of lipid nanoparticles, making them a key component in future pharmaceutical advancements.
Key Vendors
ABF Ingredients – ABITEC
BASF
Croda International
Gattefosé
IOI Oleo GMbH
Merck KGaA
AAK
Alsiano
Biopharma PEG Scientific
CD Formulation
CLARIANT
Colorcon
CordenPharma
CREMER OLEO
Evonik
Kao Corporation
Lipoid
NOF CORPORATION
Pothe Hille & Co
The East Africa Wax Company
VAV Life Sciences (VAV)
WAXOILS
Market Segmentation
Product Type
Fats
Phospholipids
Oils
Waxes
Others
Functionality
Solubilizers & Wetting Agents
Emulsifiers & Surfactants
Structuring Agents & Lubricants
Emollients, Penetration Enhancers, & Solvents
Others
Formulation
Enteral
Injectables
Topical
End-User
Pharma & Biotech Companies
Contract Manufacturing Organizations (CMOs)
Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
Academic & Research Institutes
Geography
North America
The U.S.
Canada
Europe
Germany
Switzerland
Ireland
Belgium
Italy
France
Netherlands
The U.K.
Spain
APAC
China
Japan
India
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
Turkey
South Africa
Saudi Arabia
The UAE
The Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the lipid-based pharma excipients market. Request for Free Sample to get a glance of the report now:
What Key Findings Will Our Research Analysis Reveal?
How big is the global lipid-based pharma excipients market?
What is the growth rate of the global lipid-based pharma excipients market?
Which region dominates the global lipid-based pharma excipients market share?
Who are the key players in the global lipid-based pharma excipients market?
What are the significant trends in the lipid-based pharma excipients industry?
Global Biopharmaceutical Excipients Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
Global Biopharmaceutical Contract Manufacturing Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/biopharmaceutical-contract-manufacturing-market
Why Arizton?
100% Customer Satisfaction
24x7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton's report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
Post-Purchase Benefit
1hr of free analyst discussion
10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Sun
37 minutes ago
- Toronto Sun
Prime Minister Mark Carney visits military cemetery in Brussels ahead of EU-Canada summit
Published Jun 23, 2025 • 3 minute read Canadian Prime Minister Mark Carney (R) and his wife Diana Fox Carney (2nd R) attend a wreath laying during a visit to the Schoonselhof cemetery, on the sidelines of an EU-Canada summit, in Antwerp, on June 23, 2025. Photo by JASPER JACOBS / AFP BRUSSELS — Prime Minister Mark Carney began official events for his four-day trip to Europe Monday by visiting a military cemetery in Belgium before a meeting with European counterparts at the EU-Canada summit. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account Carney said on social media Sunday he was in Brussels to launch 'a new era of partnership' between Canada and the European Union to benefit workers, businesses and security 'on both sides of the Atlantic.' Carney started the day with a visit to the Antwerp Schoonselhof Military Cemetery, where 348 Canadian soldiers are buried. Carney toured the cemetery alongside his wife, Diana Fox Carney, and Belgian Prime Minister Bart De Wever. Carney also took part in a wreath-laying ceremony with Foreign Affairs Minister Anita Anand and National Defence Minister David McGuinty. Stephane Dion, special envoy to the European Union and Europe, also attended. Carney is expected to meet later Monday with De Wever, European Council President Antonio Costa and European Commission President Ursula von der Leyen. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. At the EU-Canada summit, Anand and McGuinty are expected to sign a security and defence agreement with the European bloc — an agreement one European official described last week as one of the most ambitious deals the continent's powers have ever signed with a third country. The security and defence agreement opens the door to joint purchases of weapons with European countries and participation in the ReArm Europe initiative — which will allow Canada to access a 150-billion-euro program for defence procurement called Security Action for Europe. Canada will need to sign a second agreement with the European Commission before it can take part in the program. A government official briefing reporters on the trip said the partnership is expected to make procurement easier and more affordable, while also allowing Canada to diversify its sources of equipment. This advertisement has not loaded yet, but your article continues below. At the EU-Canada summit, leaders are also expected to issue a joint statement pressing Russia to end its war on Ukraine through measures like further sanctions, and calling for an immediate and permanent ceasefire in Gaza. The joint statement is also expected to touch on climate change, trade and digital and tech policy. De Wever said Canada's partnership with the EU is critical now because 'we've woken up in a world that doesn't look that friendly anymore.' 'We're living in a world where we have an imperialist power in the east who uses military force, we have a peculiar figure in the White House who is choosing the road of protectionism and even isolationism. So those who like a rules-based world, a multilateral world, should find each other's company now,' the Belgian prime minister said. This advertisement has not loaded yet, but your article continues below. De Wever said allies will need to spend more on defence and should do so wisely by developing their industrial defence bases together. 'Those countries who still like multilateralism are the countries that have to look up each other's company and make good agreements,' he said. Carney posted on social media early Monday that he spoke with U.S. President Donald Trump overnight. He said the conversation addressed the need to de-escalate the conflict in the Middle East. Carney said he and Trump also spoke about trade and their shared commitment to a stronger NATO. Carney has called for a 'diplomatic solution' in the wake of U.S. strikes on three key nuclear facilities in Iran. In a statement Sunday, Carney called Iran's nuclear program a 'grave threat' to international security and said Canada has been 'consistently clear' that Iran can never be allowed to develop a nuclear weapon. This advertisement has not loaded yet, but your article continues below. Speaking to reporters Monday, De Wever said he had no sympathy for the 'evil' Iranian regime and called the country a 'big sponsor of terrorism.' De Wever said that while there should be regime change in Iran, it would be preferable if it came through a democratic process and not one that 'starts with bombing.' Leaders at the EU-Canada summit are also expected to discuss global trade and commit to working toward ratifying and implementing the Comprehensive Economic and Trade Agreement, the Canada-Europe free trade deal known as CETA. The pact took effect provisionally in 2017, and most of its contents now apply. But all EU countries need to approve CETA before it can take full effect; 10 members still haven't ratified the deal. Carney, Costa and von der Leyen are scheduled to hold a joint press conference Monday evening. On Tuesday, Carney travels to The Hague for the NATO summit. The international meetings come as Canada looks to reduce its defence procurement reliance on the United States due to strained relations over tariffs and Trump's repeated talk about Canada becoming a U.S. state. Toronto & GTA Toronto Maple Leafs Sunshine Girls Sunshine Girls MLB
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
‘Craziest' reversal of fortune puts Mavs on path to Flagg after all the Doncic drama
DALLAS (AP) — Dallas Mavericks CEO Rick Welts wasn't thinking even for a second about Cooper Flagg when he started a staff meeting before the draft lottery by saying the club was entering the most important offseason in franchise history. The longtime NBA executive and relatively new leader on the business side of the Mavs was thinking about the lingering fallout of the widely reviled Luka Doncic trade, not the club turning a 1.8% chance into winning the rights to draft the teenaged star from Duke. Dallas is set to make that pick Wednesday night. 'Never, ever did anybody in our organization ever even say what would happen if we win. That's a waste of time,' Welts told The Associated Press recently. 'Like, it's unbelievable. It was hard to even get your head around.' The self-inflicted wounds were numerous after general manager Nico Harrison's stunning decision to send Doncic to the Los Angeles Lakers for Anthony Davis in early February. Fans were incensed. Season-ticket holders were canceling. Potential new sponsors were telling Welts they'd have to think about it. Just like that, the Mavs had a vision to sell of a potential superstar who could someday be the face of the franchise — as Doncic was, and fellow European superstar Dirk Nowitzki before him. Just like that, despair turned to hope for plenty of people, including those under Welts who had spent weeks dealing with the wrath of a spurned fan base. 'It's got to be the craziest reversal of fortune,' Welts said. 'It would match any in the league's history.' Before the Doncic trade, Welts had already made a decision to raise season-ticket prices. He told the AP he had to back off on the size of the increase as he watched the visceral reaction unfold. Welts has seen plenty in nearly 50 years with the NBA, including time in the league office and stints with Phoenix and Golden State. Magic Johnson's HIV announcement. Accusations of widespread drug use in the early 1980s, when he says there was a widespread belief that the league would fail. That's not to say the Doncic fallout didn't have a profound impact on the 72-year-old Welts, who had come out of retirement to replace Cynt Marshall just a month and a half earlier. It just means he has weathered a few storms. And now the Naismith Basketball Hall of Famer isn't so sure he's ever seen the sun come back out so quickly. 'The thing that I learned through all of this experience was what I knew was like this amazing emotional tie between this team and these fans was even stronger than I think anybody who hadn't lived here and been a part of it could ever imagine,' Welts said. 'Just the outpouring of pure joy and the idea of a generational player that could change our fortunes for the next 15 years would land with us by pure luck.' Harrison's widely panned decision on Doncic was compounded by an injury to Davis in his Dallas debut, followed by Kyrie Irving's season-ending knee injury a month later. The Mavs made the play-in tournament and won at Sacramento before their season — mercifully, perhaps — ended in a loss at Memphis with the No. 8 seed at stake. Part of what made the Doncic deal so hard to believe was unloading a 25-year-old superstar in his prime nine months after leading Dallas to the NBA Finals for the first time in 13 years. The Mavs lost to Boston in five games last June. Harrison's reasoning was prioritizing defense, and his belief that Davis and Irving were a good enough tandem to keep Dallas as a championship contender. Flagg's potential gave that notion a boost. 'I feel like I'm a broken record, but the team that we intended to put on the floor, which you guys saw for 2 1/2 quarters, that's a championship-caliber team,' Harrison said. 'And so you might not like it, but that's the fact, it is.' Welts, who believes the Mavs have work to do to bring their basketball and business sides together, will spend plenty of time during the early days of the Flagg era sharing his vision for a new arena. It's a big reason Welts took the job, after spending seven years with Golden State on an arena plan that moved the Warriors across the bay to San Francisco from Oakland. He says all the talks are focused on keeping the team in Dallas. Winnipeg Jets Game Days On Winnipeg Jets game days, hockey writers Mike McIntyre and Ken Wiebe send news, notes and quotes from the morning skate, as well as injury updates and lineup decisions. Arrives a few hours prior to puck drop. While the casino-centered Adelson and Dumont families of Las Vegas, in the middle of their second full year as owners of the Mavs, wanted gambling to be part of the formula for a new arena, the political realities in Texas have shifted the focus away from that idea for now. There's a new focus for Welts in what seems certain will be the final stop in an eventful NBA career: building everything around another potentially generational star after the Mavs jettisoned the one they had. 'Don't make this sound like I'm suggesting that everyone is forgiven,' Welts said. 'Luka will always be a big part of what this organization is. But for a large number of fans, it is a pathway — it's not a pathway, it's like a four-lane highway into being able to care about the Mavericks the way they cared about the Mavericks before.' ___ AP NBA:
National Observer
an hour ago
- National Observer
Prime Minister Carney is in Brussels today for EU-Canada summit
Prime Minister Mark Carney is in Belgium today, where he visited a military cemetery before meeting with European Union leaders at an EU-Canada summit. Carney said on social media Sunday that he was in Brussels to launch "a new era of partnership" between Canada and the European Union for the benefit of workers, businesses and security "on both sides of the Atlantic." Carney started the day with a visit to the Antwerp Schoonselhof Military Cemetery where 348 Canadian soldiers are buried. Carney toured the cemetery alongside his wife, Diana Fox Carney, and Belgian prime minister Bart De Wever. Carney also took part in a wreath-laying ceremony. Foreign affairs minister Anita Anand, national defence minister David McGuinty and Special Envoy to the European Union and Europe Stéphane Dion were also at the event. Later, he is expected to meet with De Wever, European Council President António Costa and European Commission President Ursula von der Leyen. Carney posted on social media early on Monday that he spoke with US President Donald Trump overnight, noting the conversation addressed the need to de-escalate the conflict in the Middle East, their shared commitment of a stronger NATO and progress in ongoing trade talks between Canada and the United States. At the EU-Canada summit, Foreign Affairs Minister Anita Anand and Defence Minister David McGuinty are expected to sign a security and defence agreement with the European bloc in what one European official described last week as one of the most ambitious deals the continent's powers have ever signed with a third country. The security and defence agreement aims to open the door to Canada's participation in the joint purchase of weapons with European countries. It will also lead to Canada's participation in the ReArm Europe initiative, allowing Canada to access a 150-billion-euro program for defence procurement, called Security Action for Europe. Canada will need to sign a second agreement with the European Commission before it can take part in the program. A government official briefing reporters on the trip said the partnership is expected to make procurement easier and more affordable, while also allowing Canada to diversify the sources of equipment. At the EU-Canada summit, leaders are also expected to issue a joint statement to underscore a willingness for continued pressure on Russia to end its war on Ukraine, including through further sanctions, and call for an immediate and permanent ceasefire in Gaza. The joint statement is also expected to touch on climate change, trade and digital and tech policy. Speaking to reporters Monday, De Wever said Canada's partnership with the EU is important because "we've woken up in a world that doesn't look that friendly anymore." "We're living in a world where we have an imperialist power in the east who uses military force, we have a peculiar figure in the White House who is choosing the road of protectionism and even isolationism, so those who like a rules-based world, a multilateral world, should find each other's company now," the Belgian prime minister said. De Wever said countries will need to spend more on defense and should do so wisely by developing their industrial defense base together. "Those countries who still like multilateralism are the countries that have to look up each other's company and make good agreements," he said. Leaders at the EU-Canada summit are also slated to discuss global trade and commit to working toward full ratification and implementation of the Comprehensive Economic and Trade Agreement, the Canada-Europe free trade deal known as CETA. The pact took effect provisionally in 2017, and most of its contents now apply. But all EU countries need to approve CETA before it can take full effect, with 10 members still left to ratify the deal. Carney, Costa and von der Leyen are scheduled to hold a joint press conference in the evening. On Tuesday, Carney travels to The Hague for the NATO summit. The international meetings come as Canada looks to reduce its defence procurement reliance on the United States due to strained relations over tariffs and US President Donald Trump's repeated talk about Canada becoming a US state.
